adidas (ADS) Given a €222.00 Price Target at Kepler Capital Markets

Kepler Capital Markets set a €222.00 ($258.14) target price on adidas (FRA:ADS) in a report published on Tuesday. The brokerage currently has a buy rating on the stock.

A number of other equities research analysts also recently issued reports on ADS. Baader Bank set a €220.00 ($255.81) price target on adidas and gave the company a buy rating in a research report on Wednesday, July 4th. Hauck & Aufhaeuser set a €240.00 ($279.07) price objective on adidas and gave the stock a buy rating in a research note on Tuesday, July 3rd. UBS Group restated a buy rating on shares of adidas in a research note on Wednesday, October 17th. Royal Bank of Canada set a €220.00 ($255.81) price objective on adidas and gave the stock a buy rating in a research note on Thursday, August 9th. Finally, HSBC set a €240.00 ($279.07) price objective on adidas and gave the stock a buy rating in a research note on Tuesday, July 3rd. Ten equities research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. The company has a consensus rating of Buy and a consensus target price of €224.68 ($261.26).

ADS stock opened at €208.10 ($241.98) on Tuesday. adidas has a 12-month low of €163.65 ($190.29) and a 12-month high of €201.01 ($233.73).

adidas Company Profile

adidas AG, together with its subsidiaries, designs, develops, produces, and markets athletic and sports lifestyle products worldwide. It offers footwear; apparel; and hardware, such as bags and balls under the adidas, Reebok, and adidas Golf brands. The company is also involved in Y-3 label business activities; and the operation of Runtastic, a digital health and fitness space.

Read More: What are earnings reports?

Analyst Recommendations for adidas (FRA:ADS)

Receive News & Ratings for adidas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for adidas and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply